Brain tumours are diverse group of primary CNS tumours and secondary neoplasm arising either from the scalp or from haematogenous spread from distant sites with few biologically aggressive tumours in both adult and paediatric age groups. Brain tumours have been classified based on their presumed cell of origin and degree of differentiation as determined by light microscopy and immunohistochemical studies with tumours distinctive tumour biology, treatment and prognosis. A retrospective study of all cases of intracranial tumours seen over a period of 10 years from January 2008 to December 2017 at Department of Pathology, Usmanu Danfodiyo University Teaching Hospital. This is a regional neurosurgical centre situated at Sokoto North-West Nigeria receiving surgical specimens from Birnin Kebbi, Zamfara, Sokoto, and Katsina state. The age, sex, histologic diagnosis, and histologic grading system using the 2007 WHO grading system were retrieved and recorded. This study reviewed 151 patients managed with histology confirmed intracranial tumour (ICTs). Mean age was 28.17 ±17.26 years. The male-to-female ratio was 1.6:1.0. Peak age range was the third decade (21-30years) and accounted for (20.5%). Primary ICTs accounted for 95.4% of the cases and metastatic adenocarcinomas accounted for 4.6% of the diagnoses and all the cases were seen in adults. Meningioma was the most commonly diagnosed intracranial tumours (39.7%), followed by astrocytoma (23.2%), pituitary adenomas (7.3%), craniopharyngioma (11.9%) and nodular medulloblastoma accounted for 4.0%. The most common histologic subtype of meningioma was psammomatous accounted for 75.5%, followed by meningotheliomatous 18.5% and the least was transitional 1.3%. The mean age of meningioma was 32±11.9 years with age range from 3 – 58years and male to female ratio of 1.4:1 and WHO classification of meningioma are stratified into 3; 95% are in grade 1 and 5% are in grade 11. Meningioma was the most commonly diagnosed intracranial tumours (39.7%), followed by astrocytoma (23.2%), pituitary adenomas (7.3%), craniopharyngioma (11.9%) and nodular medulloblastoma accounted for 4.0%. The most common histologic subtype of meningioma was psammomatous accounted for 75.5%, followed by meningotheliomatous 18.5% and the least was transitional 1.3% with WHO classification of meningioma are stratified into 3; 95% are in grade 1 and 5% are in grade 11.
Published in | American Journal of Laboratory Medicine (Volume 4, Issue 6) |
DOI | 10.11648/j.ajlm.20190406.17 |
Page(s) | 119-123 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Histopathological Pattern, Intracranial Tumour, Meningioma, Glioma, Embryonal Tumours
[1] | Sunday Sokunle Soyemi and, Olugbenga Olayide Oyewole. Spectrum of intracranial tumours in a tertiary health carefacility: our findings. Pan African Medical Journal. 2015; 20 (24): 1-5. |
[2] | Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L. Siegel, Lindsey A. Torre, Ahmedin Jemal. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018; 0 (0): 3-31. |
[3] | McKinney PA. Brain tumours: Incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry. 2004; 75 (2): 12-7. |
[4] | Davis FG, McCarthy BJ. Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther. 2001; 1: 395-401. |
[5] | Ohaegbulam SC. Geographical neurosurgery. Neurol Res. 1999; 21: 161-70. |
[6] | Ogun GO. Diagnosis and management of brain tumours at Jos University Teaching Hospital, Nigeria. East Afr Med J. 2001; 78: 148-51. |
[7] | Chika Anele Ndubuisi, Samuel C. Ohaegbulam, Linda U. Iroegbu, Mike Ezeali Ekuma, Wilfred C. Mezue, and Uwadiegwu Alphonsus ErechukwuHistologically Confirmed Intracranial Tumors Managed at Enugu, Nigeria. J Neurosci Rural Pract. 2017; 8 (4): 585-590. |
[8] | Idowu O, Akang E, Malomo A. Symptomatic primary intracranial neoplasm in Nigeria. West Afri. J NeurolSci (Turk) 2007; 19 (24): 212-218. |
[9] | Ibebuike K, Ouma J, Gopal R. Meningiomas among intracranial neoplasms in Johannesburg, South Africa: prevalence, clinical observations and review of the literature. African Health Sciences. 2013; 13: 118–121. |
[10] | Paul Jibrin, Kaunda Ibebuike, Aisha Nabila Ado-wanka. Histo-pathological pattern of intracranial tumours in the National Hospital, Abuja African Health Sciences. 2018; 18 (2): 281-286. |
[11] | Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nercous tumors in Korea: J Korean Neurosurg Soc. 2010; 48 (2): 145-52. |
[12] | Ghanghoria S, Mehar R, Kulkarni CV, Mithal M, Yadev A, Patidar H. Reterospective histopathological analysis of CNS tumors- A 5 years study. International Journal of Medical Science and Public Health. 2014; 3 (10): 1205-7. |
[13] | Majid N, Ali Z, Rahman MR, Akhter A, Rajib RC, Saha UK. Histological subtypes of brain tumor: pattern in a hospital in Dhaka, Bangladesh. Chatt Maa Shi Hosp Med Coll J. 2013; 12 (1): 9-11. |
[14] | Mohammad Sajjad, Hamidullah Shah, Zard Ali Khan, Shafi Ullah. Histopathological pattern of intracranial tumors in a Tertiary care Hospital of Peshawar, Pakistan. JSZMC. 2015; 7 (1): 909-912. |
[15] | Olasode BJ, Shokunbi Mt, Aghadiuno PU. Intracranial Neoplasms in Ibadan, Nigeria. East Afr Med J. 2000; 77: 4-8. |
[16] | Abdul Rashid Bhat, Muhammed Afzal Wani, Altaf Rehman Kirmani, and Altaf Umar Ramzan. Histological-subtypes and anatomical location correlated in meningeal brain tumors meningiomas. J Neurosci Rural Pract. 2014; 5 (3): 244–249. |
[17] | Abu Khalid Muhammad Maruf Raza1, Ferdous Ahmed, Tajrin Akter Munni, Zabed Ahmed Mitu, and Shahriar Masood. Histomorphological spectrum of meningioma with variants and grading. Adv Surg Res. 2017; 1 (1): 15-17. |
[18] | Thomas Backer-Grøndahl, Bjørnar H Moen, Sverre H Torp. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol. 2012; 5 (3): 231-242. |
[19] | Ahsan J, Hashmi SN, Mohammad I, Din HU, Butt AM, Nazir S, Azhar M. Spectrum of CNS tumors- A single center histopathological review of 761 cases over 5 years. JAMC, 2015; 27 (1): 81-4. |
[20] | Butt ME, Khan SA, Chaudrh NA, Qureshi GR. Intracranial spac occupying lesions A morphological analysis. Biomedica, 2005; 21 (1): 31-5. |
[21] | Ahmed Z, Kayani MN, Pervez S, Husainy AS, Hasan SH. Histopathological pattern of central nervous system neoplasm. J Pak Med Assoc. 2001; 51 (4): 154-7. |
APA Style
Sahabi Sadiku Malami, Rasheed Mumini Wemimo, Abdullahi Kabiru, Adegboye Adeyemi Taiwo, Mohammed Umar, et al. (2019). Histopathological Patterns of Intracranial Tumours at a Tertiary Health Facility in Sokoto, North-West Nigeria. American Journal of Laboratory Medicine, 4(6), 119-123. https://doi.org/10.11648/j.ajlm.20190406.17
ACS Style
Sahabi Sadiku Malami; Rasheed Mumini Wemimo; Abdullahi Kabiru; Adegboye Adeyemi Taiwo; Mohammed Umar, et al. Histopathological Patterns of Intracranial Tumours at a Tertiary Health Facility in Sokoto, North-West Nigeria. Am. J. Lab. Med. 2019, 4(6), 119-123. doi: 10.11648/j.ajlm.20190406.17
AMA Style
Sahabi Sadiku Malami, Rasheed Mumini Wemimo, Abdullahi Kabiru, Adegboye Adeyemi Taiwo, Mohammed Umar, et al. Histopathological Patterns of Intracranial Tumours at a Tertiary Health Facility in Sokoto, North-West Nigeria. Am J Lab Med. 2019;4(6):119-123. doi: 10.11648/j.ajlm.20190406.17
@article{10.11648/j.ajlm.20190406.17, author = {Sahabi Sadiku Malami and Rasheed Mumini Wemimo and Abdullahi Kabiru and Adegboye Adeyemi Taiwo and Mohammed Umar and Afolayan Enoch Abiodun and Oluogun Waheed Akanni and Mohammad Shareef Bello and Nasiru Jinjiri Ismail}, title = {Histopathological Patterns of Intracranial Tumours at a Tertiary Health Facility in Sokoto, North-West Nigeria}, journal = {American Journal of Laboratory Medicine}, volume = {4}, number = {6}, pages = {119-123}, doi = {10.11648/j.ajlm.20190406.17}, url = {https://doi.org/10.11648/j.ajlm.20190406.17}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20190406.17}, abstract = {Brain tumours are diverse group of primary CNS tumours and secondary neoplasm arising either from the scalp or from haematogenous spread from distant sites with few biologically aggressive tumours in both adult and paediatric age groups. Brain tumours have been classified based on their presumed cell of origin and degree of differentiation as determined by light microscopy and immunohistochemical studies with tumours distinctive tumour biology, treatment and prognosis. A retrospective study of all cases of intracranial tumours seen over a period of 10 years from January 2008 to December 2017 at Department of Pathology, Usmanu Danfodiyo University Teaching Hospital. This is a regional neurosurgical centre situated at Sokoto North-West Nigeria receiving surgical specimens from Birnin Kebbi, Zamfara, Sokoto, and Katsina state. The age, sex, histologic diagnosis, and histologic grading system using the 2007 WHO grading system were retrieved and recorded. This study reviewed 151 patients managed with histology confirmed intracranial tumour (ICTs). Mean age was 28.17 ±17.26 years. The male-to-female ratio was 1.6:1.0. Peak age range was the third decade (21-30years) and accounted for (20.5%). Primary ICTs accounted for 95.4% of the cases and metastatic adenocarcinomas accounted for 4.6% of the diagnoses and all the cases were seen in adults. Meningioma was the most commonly diagnosed intracranial tumours (39.7%), followed by astrocytoma (23.2%), pituitary adenomas (7.3%), craniopharyngioma (11.9%) and nodular medulloblastoma accounted for 4.0%. The most common histologic subtype of meningioma was psammomatous accounted for 75.5%, followed by meningotheliomatous 18.5% and the least was transitional 1.3%. The mean age of meningioma was 32±11.9 years with age range from 3 – 58years and male to female ratio of 1.4:1 and WHO classification of meningioma are stratified into 3; 95% are in grade 1 and 5% are in grade 11. Meningioma was the most commonly diagnosed intracranial tumours (39.7%), followed by astrocytoma (23.2%), pituitary adenomas (7.3%), craniopharyngioma (11.9%) and nodular medulloblastoma accounted for 4.0%. The most common histologic subtype of meningioma was psammomatous accounted for 75.5%, followed by meningotheliomatous 18.5% and the least was transitional 1.3% with WHO classification of meningioma are stratified into 3; 95% are in grade 1 and 5% are in grade 11.}, year = {2019} }
TY - JOUR T1 - Histopathological Patterns of Intracranial Tumours at a Tertiary Health Facility in Sokoto, North-West Nigeria AU - Sahabi Sadiku Malami AU - Rasheed Mumini Wemimo AU - Abdullahi Kabiru AU - Adegboye Adeyemi Taiwo AU - Mohammed Umar AU - Afolayan Enoch Abiodun AU - Oluogun Waheed Akanni AU - Mohammad Shareef Bello AU - Nasiru Jinjiri Ismail Y1 - 2019/12/17 PY - 2019 N1 - https://doi.org/10.11648/j.ajlm.20190406.17 DO - 10.11648/j.ajlm.20190406.17 T2 - American Journal of Laboratory Medicine JF - American Journal of Laboratory Medicine JO - American Journal of Laboratory Medicine SP - 119 EP - 123 PB - Science Publishing Group SN - 2575-386X UR - https://doi.org/10.11648/j.ajlm.20190406.17 AB - Brain tumours are diverse group of primary CNS tumours and secondary neoplasm arising either from the scalp or from haematogenous spread from distant sites with few biologically aggressive tumours in both adult and paediatric age groups. Brain tumours have been classified based on their presumed cell of origin and degree of differentiation as determined by light microscopy and immunohistochemical studies with tumours distinctive tumour biology, treatment and prognosis. A retrospective study of all cases of intracranial tumours seen over a period of 10 years from January 2008 to December 2017 at Department of Pathology, Usmanu Danfodiyo University Teaching Hospital. This is a regional neurosurgical centre situated at Sokoto North-West Nigeria receiving surgical specimens from Birnin Kebbi, Zamfara, Sokoto, and Katsina state. The age, sex, histologic diagnosis, and histologic grading system using the 2007 WHO grading system were retrieved and recorded. This study reviewed 151 patients managed with histology confirmed intracranial tumour (ICTs). Mean age was 28.17 ±17.26 years. The male-to-female ratio was 1.6:1.0. Peak age range was the third decade (21-30years) and accounted for (20.5%). Primary ICTs accounted for 95.4% of the cases and metastatic adenocarcinomas accounted for 4.6% of the diagnoses and all the cases were seen in adults. Meningioma was the most commonly diagnosed intracranial tumours (39.7%), followed by astrocytoma (23.2%), pituitary adenomas (7.3%), craniopharyngioma (11.9%) and nodular medulloblastoma accounted for 4.0%. The most common histologic subtype of meningioma was psammomatous accounted for 75.5%, followed by meningotheliomatous 18.5% and the least was transitional 1.3%. The mean age of meningioma was 32±11.9 years with age range from 3 – 58years and male to female ratio of 1.4:1 and WHO classification of meningioma are stratified into 3; 95% are in grade 1 and 5% are in grade 11. Meningioma was the most commonly diagnosed intracranial tumours (39.7%), followed by astrocytoma (23.2%), pituitary adenomas (7.3%), craniopharyngioma (11.9%) and nodular medulloblastoma accounted for 4.0%. The most common histologic subtype of meningioma was psammomatous accounted for 75.5%, followed by meningotheliomatous 18.5% and the least was transitional 1.3% with WHO classification of meningioma are stratified into 3; 95% are in grade 1 and 5% are in grade 11. VL - 4 IS - 6 ER -